Background: Herpes zoster (HZ) in patients receiving tumor necrosis factor (TNF) antagonists may be more severe and the incidence seems increased. The influence of TNF antagonists on varicella zoster virus (VZV) reactivation is unknown.
Objective: To prospectively search in a pilot study for VZV DNA in sequential blood samples before and after infliximab administration.
Setting: University medical center.
Subjects And Methods: Blood samples of six patients with longstanding and severe plaque psoriasis were taken on day 1 (before infliximab administration) and on days 2, 7, 21 and 42 for the determination of VZV viremia by ORF21 real-time polymerase chain reaction. Patients with varicella, HZ and normal subjects were included as controls.
Results: None of the six patients presented VZV viremia at any of the time points. High-load viremia was present during varicella, low-load viremia in some HZ patients and no viremia in the control patients.
Limitations: Small number of patients.
Conclusions: In this pilot study, infliximab did not reactivate VZV and did not induce subclinical VZV viremia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000369453 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Viral modulation of type II interferon increases T cell adhesion and virus spread.
Nat Commun
June 2024
Institute of Virology, Hannover Medical School, Hannover, 30625, Germany.
During primary varicella zoster virus (VZV) infection, infected lymphocytes drive primary viremia, causing systemic dissemination throughout the host, including the skin. This results in cytokine expression, including interferons (IFNs), which partly limit infection. VZV also spreads from skin keratinocytes to lymphocytes prior to secondary viremia.
View Article and Find Full Text PDFEstablishment and application of a gold nanoparticle-based immunochromatographic test strip for the detection of avian leukosis virus P27 antigen in egg white samples.
Analyst
April 2024
State Key Lab of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, People's Republic of China.
Avian leukemia is an infectious tumorous disease of chickens caused by subgroup A of the avian leukemia virus (ALV-A), which mainly causes long-term viremia, slow growth, immune suppression, decreased production performance, multi-tissue tumors, and even death. The infection rate of this disease is very high in chicken herds in China, causing huge economic losses to the poultry industry every year. We successfully expressed the specific antigen protein of ALV (P27) through recombinant protein technology and screened a pair of highly sensitive monoclonal antibodies (mAbs) through mouse immunity, cell fusion, and antibody pairing.
View Article and Find Full Text PDFImmune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
BMC Infect Dis
March 2024
HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Background: The burden of herpes zoster (shingles) virus and associated complications, such as post-herpetic neuralgia, is higher in older adults and has a significant impact on quality of life. The incidence of herpes zoster and post-herpetic neuralgia is increased in people living with HIV (PLWH) compared to an age-matched general population, including PLWH on long-term antiretroviral therapy (ART) with no detectable viremia and normal CD4 counts. PLWH - even on effective ART may- exhibit sustained immune dysfunction, as well as defects in cells involved in the response to vaccines.
View Article and Find Full Text PDFTime course of skin rash, computed tomography findings, and viral load in a rheumatoid arthritis patient with severe varicella pneumonia.
IDCases
July 2023
Department of Respiratory Medicine, Handa City Hospital, 2-29 Touyou-cho, Handa-shi, Aichi 475-8599, Japan.
Article Synopsis
- * The patient had a variety of lung issues observed on a chest CT and was treated with acyclovir; her skin rash improved within five days, while respiratory symptoms took about two weeks to start improving.
- * Notably, the case also revealed HHV-6 reactivation in the patient, but it resolved on its own, highlighting the need for careful assessment when determining treatment options for HHV-6 in VZV pneumonia cases.
Viral modulation of type II interferon increases T cell adhesion and virus spread.
bioRxiv
May 2023
Institute of Virology, Hannover Medical School, Hannover 30625, Germany.
During primary infection, varicella zoster virus (VZV) infects epithelial cells in the respiratory lymphoid organs and mucosa. Subsequent infection of lymphocytes, T cells in particular, causes primary viremia allowing systemic spread throughout the host, including the skin. This results in the expression of cytokines, including interferons (IFNs) which partly limit primary infection.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!